002773 Stock Overview
Research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Chengdu Kanghong Pharmaceutical Group Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥19.42 |
| 52 Week High | CN¥24.50 |
| 52 Week Low | CN¥13.15 |
| Beta | 0.14 |
| 1 Month Change | 2.16% |
| 3 Month Change | 11.16% |
| 1 Year Change | 6.00% |
| 3 Year Change | 1.73% |
| 5 Year Change | -46.03% |
| Change since IPO | 93.11% |
Recent News & Updates
With EPS Growth And More, Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Makes An Interesting Case
Dec 12
Insufficient Growth At Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE:002773) Hampers Share Price
Sep 15Recent updates
With EPS Growth And More, Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Makes An Interesting Case
Dec 12Insufficient Growth At Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE:002773) Hampers Share Price
Sep 15Here's Why We Think Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Is Well Worth Watching
Jun 21Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Price Is Right But Growth Is Lacking After Shares Rocket 40%
May 12Lacklustre Performance Is Driving Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Low P/E
Mar 27Shareholder Returns
| 002773 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.2% | -3.1% | -2.1% |
| 1Y | 6.0% | -4.4% | 9.8% |
Return vs Industry: 002773 exceeded the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 002773 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 002773 volatility | |
|---|---|
| 002773 Average Weekly Movement | 6.3% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 002773 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002773's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 4,289 | Xiao Ke | www.cnkh.com |
Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. It also develops ophthalmic medical devices. The company offers central nervous, digestive, and endocrine system drugs.
Chengdu Kanghong Pharmaceutical Group Co., Ltd Fundamentals Summary
| 002773 fundamental statistics | |
|---|---|
| Market cap | CN¥17.86b |
| Earnings (TTM) | CN¥1.19b |
| Revenue (TTM) | CN¥4.37b |
15.0x
P/E Ratio4.1x
P/S RatioIs 002773 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002773 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.37b |
| Cost of Revenue | CN¥457.72m |
| Gross Profit | CN¥3.91b |
| Other Expenses | CN¥2.72b |
| Earnings | CN¥1.19b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.30 |
| Gross Margin | 89.53% |
| Net Profit Margin | 27.30% |
| Debt/Equity Ratio | 0% |
How did 002773 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield29%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 01:43 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chengdu Kanghong Pharmaceutical Group Co., Ltd is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Weiya Zhang | BOCI Research Ltd. |
| Yue Gao | Changjiang Securities Co. LTD. |
| Ziyu He | China International Capital Corporation Limited |